Chemoinformaics analysis of 2-deoxo-2-(acetyloxy)-9-oxoageraphorone
| Molecular Weight | 278.392 | nRot | 2 |
| Heavy Atom Molecular Weight | 252.184 | nRig | 13 |
| Exact Molecular Weight | 278.188 | nRing | 2 |
| Solubility: LogS | -2.713 | nHRing | 0 |
| Solubility: LogP | 2.899 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 46 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 48.1326 |
| nHD | 0 | BPOL | 29.5554 |
| QED | 0.574 |
| Synth | 4.315 |
| Natural Product Likeliness | 2.301 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.024 |
| Pgp-sub | 0.003 |
| HIA | 0.028 |
| CACO-2 | -4.556 |
| MDCK | 0.0000134 |
| BBB | 0.977 |
| PPB | 0.912112 |
| VDSS | 1.102 |
| FU | 0.0568343 |
| CYP1A2-inh | 0.063 |
| CYP1A2-sub | 0.172 |
| CYP2c19-inh | 0.029 |
| CYP2c19-sub | 0.92 |
| CYP2c9-inh | 0.166 |
| CYP2c9-sub | 0.224 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.24 |
| CYP3a4-inh | 0.206 |
| CYP3a4-sub | 0.605 |
| CL | 11.474 |
| T12 | 0.154 |
| hERG | 0.009 |
| Ames | 0.018 |
| ROA | 0.38 |
| SkinSen | 0.04 |
| Carcinogencity | 0.084 |
| EI | 0.023 |
| Respiratory | 0.229 |
| NR-Aromatase | 0.002 |
| Antiviral | Yes |
| Prediction | 0.67155 |